Plus, news about Kezar Life Sciences, Elicio Therapeutics and Viracta Therapeutics:
Avidity seeks $250M in public offering: The money will be used in part to …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Listen to the article 7 min This audio is auto-generated. Please let us know if you have feedback. Abbott secured Food and Drug Administration approval
Shingles still doesn’t care in GSK’s renewed campaign for its Shingrix vaccine. The initial “Shingles Doesn’t Care” campaign, launched in 2020, showed active adults ages
California’s new initiative to compel treatment for some of the state’s most severely mentally ill residents — many of whom are living on the streets